Repligen Corp (RGEN)
NASDAQ:RGEN

Repligen (RGEN) Similar Stocks

907 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Repligen
$6.92B
490.53
-29.39%
7 Buy
3 Hold
0 Sell
Moderate Buy
$183.40
Atara Biotherapeutics
$54.00M
-0.30
-79.03%
1 Buy
3 Hold
1 Sell
Hold
$26.38
Alnylam Pharma
$30.08B
-88.65
23.66%
14 Buy
6 Hold
0 Sell
Moderate Buy
$267.58
Arrowhead Pharmaceuticals
$3.51B
-6.68
-19.28%
7 Buy
4 Hold
0 Sell
Moderate Buy
$45.70
Fate Therapeutics
$486.06M
-2.23
-4.26%
5 Buy
8 Hold
0 Sell
Moderate Buy
$6.55

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
RGEN
Repligen
123.81
-52.70
-29.86%
ATRA
Atara Biotherapeutics
11.01
-39.99
-78.41%
ALNY
Alnylam Pharma
237.83
45.51
23.66%
ARWR
Arrowhead Pharmaceuticals
28.30
-6.76
-19.28%
FATE
Fate Therapeutics
4.27
-0.04
-0.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis